Associate Professor Dr.Sawitree Chiampanichayakul
Assistant Professor Dr. Sawitree Chiampanichayakul, Ph.D Member of AMS Cancer Research Unit and MT Cancer research Unit, Faculty of Associated Medical Sciences, Chiang Mai University, Thailand. Assistant Professor Dr. Sawitree Chiampanichayakul is Assistant Professor of Medical Technology within Faculty of Associated Medical Sciences at the Chiang Mai University, Thailand. Sawitree Chiampanichayakul graduated from Department of Biochemistry, Faculty of Medicine, Chiang Mai University. She completed her doctoral research on Cellular Distribution, Biochemical Characterization, Function and Molecular Cloning of Gene Encoding P-3E10 Molecule. She has been a lecturer at Faculty of Associated Medical Sciences in the Clinical Microscopy and MT-AMS-Cancer Research Unit. Her current research interests are in the area of leukemia drug resistant and leukemic stem cells, trying to find specific molecules targeting leukemic stem cell.
1. Outstanding Dissertation Award for the topic of Cellular Distribution, Biochemical Characterization, Function and Molecular Cloning of Gene Encoding P-3E10 Molecule from Graduate School of Chiang Mai University.
2. Travel grant award Expression of CD147 Involves in Multidrug Resistance Phenotype of K562/Adr Leukemic Cell Line. The 73rd Annual Meeting of Japanese Cancer Association. Yokohama, Japan 25th-27th September 2014.
B.Sc. (Medical Technology), Chiang Mai University, Chiang Mai, Thailand
M.S. (Biochemistry), Chiang Mai University, Chiang Mai, Thailand
Ph.D. (Biochemistry), Chiang Mai University, Chiang Mai, Thailand
1. Songyot Anuchapreeda, Sawitree Chiampanichayakul, Singkome Tima. Cell Morphology. 4th Edition, Santipab Pack-Print Co. Ltd. Kaeo Nawarat Rd., Wat Ket, Mueang Chiang Mai, Chiang Mai, 50000, Thailand, 2015. 220 pp.
2. Sawitree Chiampanichayakul, Songyot Anuchapreeda, Nutjeera Intasai, Singkome Tima. Body fluids. Santipab Pack-Print Co. Ltd. Kaeo Nawarat Rd., Wat Ket, Mueang Chiang Mai, Chiang Mai, 50000, Thailand, 2015. 208 pp.
Selected current projects
1. Drug resistance in leukemia
2. Molecules involved leukemic stem cells
1. Chiampanichayakul S, Kataoka K, Arimochi H, Vinitketkumnuen U, Ohnishi Y. Effects of Momordica charantia extract on preneoplastic lesions of colon cancer in rats. Chiang Mai Med Bull 1999;38(1-2):7-12.
2. Chiampanichayakul S, Kataoka K, Arimochi H, Thumvijit S, Kuwahara T, Nakayama H, Vinitketkumnuen U, Ohnishi Y. Inhibitory effects of bitter melon (Momordica charantia Linn.) on bacterial mutagenesis and aberrant crypt focus formation in the rat colon. J Med Invest. 2001;48(1-2):88-96.
3. Chiampanichayakul S. and Kasinrerk W. Molecular cloning of leukocyte surface molecules by retrovirus-mediated expression cloning system. Bull Chiang Mai Assoc Med Sci 2001;30(1):36-44.
4. Chiampanichayakul S, Szekeres A, Khunkaewla P, Moonsom S, Leksa V, Drbal K, Zlabinger J G, Hofer-Warbinek R, Stockinger H, and Kasinrerk W. Engagement of Na,K-ATPase 3 subunit by a specific monoclonal antibody suppresses T and B lymphocyte activation. Int Immunol 2002;14(12):1407-1414.
5. Kritratanasak S, Chiampanichayakul S and Kasinrerk W. Production of IgY Anti-mouse IgG Antibodies from Chicken Eggs. Asian Pacific Journal of Allergy and Immunology. 2004;22:61-68.
6. Chiampanichayakul S, Peng-in P, Hachaibhun J, Khunkaewla P, Kasinrerk K. CD147 contains different bioactive epitopes involving the regulation of cell adhesion and lymphocyte activation. Immunobiology 2006:211(3):167-78.
7. Chiampanichayakul S, Khunkaewla P and Kasinrerk W. Na, K ATPase 3 subunit (CD298): Association with Subunit and Expression on Peripheral Blood Cells. Tissue Antigens 2006;68(6): 509-517.
8. Tatu T, Prakunwisit D, Sayajak S, Chiampanichayakul S and Kasinrerk W. RBC count and its differentiation potential among -thalassemia (SEA type), -thalassemia and HbE heterozygotes. CMU J. 2007; Vol 6 (1): 57-63.
9. Khunkaewla P, Chiampanichayakul S, Yasamut U, Pata S and Kasinrerk W. Production, Characterization, and Functional analysis of Newly Established CD99 Monoclonal Antibodies MT99/1 and MT99/2. Hybridoma 2007;26(4):241-250.
10. Tayapiwatana C, Kuntaruk S, Tatu T, Chiampanichayakul C, Munkongdee T, Winichagoon P, Fuchareon S and Kasinrerk W. Simple method for screening of -thalassaemia 1 carriers. Int J Hematology 2009;89:559-67.
11. Chiampanichayakul S, Anuchapreeda S, Chruewkamlow N, Mahasongkram K, Thanaratanakorn P, Kasinrerk W. Production of monoclonal antibodies to P-glycoprotein: Its application in detection of soluble and surface P-glycoprotein of leukemia patients. Int J Hematol 2010;92(2):326-33.
12. Apiratmateekul N, Pata S, Chiampanichayakul S, Kasinrerk W. Non-mitogen containing conditioned medium for hybridoma production and single cell cloning. Asian Pac J Allergy Immunol 2012;30:114-22.
13. Chruewkamlow N, Pata S, Mahasongkram K, Laopajon W, Kasinrerk W, Chiampanichayakul S. ?3 Subunit of Na,K ATPase Regulates T Cell Activation with No Involvement of Na,K ATPase Activity. Immunobiology 2015;220:634-640,.
14. Somno A, Anuchpreeda S, Chiampanichayakul S. Expressions of P-glycoprotein, survivin and CD147 molecules on multidrug resistance leukemic cell line K562/Adr. Bull Chiang Mai Assoc Med Sci 2015;48(3):173-181.
15. Pakdeepak K, Pata S, Chiampanichayakul S, Kasinrerk W, Tatu T. Production and characterization of monoclonal antibodies against ?-globin chain-containing human hemoglobins for detecting ?-thalassemia disease. J Immunoassay Immunochem. 2016;37(6):564-71.
16. Somno A, Anuchapreeda S, Chruewkamlow N, Pata S, Kasinrerk W, Chiampanichayakul S. Involvement of CD147 on multidrug resistance through the regulation of P-glycoprotein expression in K562/ADR leukemic cell line. Leu Res Rep 2016;6:33-38.
Research and professional experiences
Co-immunoprecipitation technique training. At Institute of Immunology-Vienna International Research Cooperation Center at NFI, University of Vienna, Brunner Strasse 59, 1235 Vienna, Austria. 1 April-30 June 2003.
Molecular cloning of leukocyte surface molecules by retrovirus-mediated expression cloning system. At Institute of Immunology-Vienna International Research Cooperation Center at NFI, University of Vienna, Brunner Strasse 59, 1235 Vienna, Austria. 14 March-30 October 2001.
The effect of Momordica charantia on the formation of aberrant crypt foci (ACF) and DNA adduct in AOM-treated rats. In Department of Bacteriology, School of Medicine, The University of Tokushima, Tokushima, 770-8503, Japan.